Clinical Trial

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing

Study acronym: EMAI-NGS
Recruiting
View on ClinicalTrials.gov →
Summary
: Encephalitis or myelitis is defined as the inflammatory or infectious involvement of the cerebral parenchyma or spinal cord. When an infectious origin is suspected, the germ is not always identified. Next-generation sequencing could be used to correct an etiological diagnosis of these severe conditions in Guadeloupe. The rate of cases for which the infectious agent is not identified encourages continued diagnostic efforts, with the objective of identifying new pathogens or emerging pathogens, some of which may be more specific in the tropics.
Trial Details
NCT Number NCT07251049
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions Acute Encephalitis, Acute Myelitis
Enrollment 100 participants
Start Date 2023-11-16
Primary Completion 2028-11-16 (estimated)
Study Completion 2028-11-16 (estimated)
Updated on ClinicalTrials.gov 2025-11-26